[Ex vivo expansion of hematopoietic stem cells: concept and clinical benefit] (Q84939310)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19932632%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

review article

1 reference

title

[Ex vivo expansion of hematopoietic stem cells: concept and clinical benefit] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19932632%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19932632%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

J-M Boiron

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19932632%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

22 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19932632%20AND%20SRC:MED&resulttype=core&format=json

Transfusion Clinique et Biologique

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19932632%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19932632%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19932632%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

489-500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19932632%20AND%20SRC:MED&resulttype=core&format=json

Can human hematopoietic stem cells be cultured ex vivo?

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

A direct measurement of the radiation sensitivity of normal mouse bone marrow cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

7 January 2021

Hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Differential short-term and long-term repopulating ability of stem cell subsets in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Distinct classes of human stem cells that differ in proliferative and self-renewal potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Biological principles for ex vivo adult stem cell expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Ex vivo expansion of hematopoietic cells. Part II: control of proliferation and differentiation of hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Expansion of human hematopoietic stem cells for transplantation: trends and perspectives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Experimental culture conditions are critical for ex vivo expansion of hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Interest of cord blood stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Thrombopoietin and the hematopoietic stem cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Oxygen in the cultivation of stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Hypoxia or in situ normoxia: The stem cell paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Where the O2 goes to: preservation of human fetal oxygen delivery and consumption at high altitude

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O2 concentration (3%).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Role of the plasma membrane ROS-generating NADPH oxidase in CD34+ progenitor cells preservation by hypoxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Comparison between the effects of normoxia and hypoxia on antioxidant enzymes and glutathione redox state in ex vivo culture of CD34(+) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

The effect of the copper chelator tetraethylenepentamine on reactive oxygen species generation by human hematopoietic progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Thrombopoietin (TPO) regulates HIF-1alpha levels through generation of mitochondrial reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

7 January 2021

Hematopoietic cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Continuous hypoxic culturing maintains activation of Notch and allows long-term propagation of human embryonic stem cells without spontaneous differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Signal control of hematopoietic stem cell fate: Wnt, Notch, and Hedgehog as the usual suspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

HOX decoy peptide enhances the ex vivo expansion of human umbilical cord blood CD34+ hematopoietic stem cells/hematopoietic progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Hoxa6 potentiates short-term hemopoietic cell proliferation and extended self-renewal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

HOXB4-induced expansion of adult hematopoietic stem cells ex vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Ex vivo expansion of autologous PB CD34+ cells provides a purging effect in children with neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

The CD34(+)CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Transplantation of ex vivo expanded cord blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

An efficient large-scale thawing procedure for cord blood cells destined for selection and ex vivo expansion of CD34+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

Cord blood processing by using a standard manual technique and automated closed system "Sepax" (Kit CS-530)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.10.002

10.1016/J.TRACLI.2009.10.002

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19932632%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference